This is a synthetic peptide designed for use in combination with anti-Vgll2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
VGLL2
Reaktivität: Maus, Human, Ratte
Wirt: Synthetic
BP
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeat freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
VGLL2
(Vestigial Like 2 (VGLL2))
Synonyme
VGL2 Peptide, VITO1 Peptide, vgll2a Peptide, MGC114146 Peptide, zgc:114146 Peptide, C130057C21Rik Peptide, VITO-1 Peptide, Vito1 Peptide, vgl-2 Peptide, zgc:110098 Peptide, vestigial like family member 2 Peptide, vestigial-like family member 2 Peptide, vestigial-like family member 2a Peptide, vestigial like family member 2 L homeolog Peptide, vestigial-like family member 2b Peptide, VGLL2 Peptide, Vgll2 Peptide, vgll2a Peptide, vgll2.L Peptide, vgll2b Peptide
Hintergrund
Vgll2 may act as a specific coactivator for the mammalian TEFs. May play a role in the development of skeletal muscles.